Selective inhibition of the duck hepatitis B virus by a new class of tetraazamacrocycles
- PMID: 9371374
- PMCID: PMC164169
- DOI: 10.1128/AAC.41.11.2579
Selective inhibition of the duck hepatitis B virus by a new class of tetraazamacrocycles
Abstract
The antiviral activity of a new class of N,N,N',N",NA'''-pentakis (omega-aminoalkyl) tetraazamacrocycles was evaluated in primary duck hepatocyte cultures infected with the duck hepatitis B virus (DHBV). Three of the four tested compounds were able to selectively inhibit DHBV replication by acting at an early step of the hepadnavirus infection but were associated with significant toxicity.
Similar articles
-
Design, synthesis and structure relationships of new N,N',N",N"'-tetrakis (omega-amino alkyl) tetraazamacrocycles.Antivir Chem Chemother. 1998 Jan;9(1):73-84. Antivir Chem Chemother. 1998. PMID: 9875379
-
Antiviral strategies in chronic hepatitis B virus infection: II. Inhibition of duck hepatitis B virus in vitro using conventional antiviral agents and supercoiled-DNA active compounds.J Med Virol. 1990 Jun;31(2):90-7. doi: 10.1002/jmv.1890310205. J Med Virol. 1990. PMID: 1696959
-
Inhibition of duck hepatitis B virus replication by 2',3'-dideoxy-3'-fluoroguanosine in vitro and in vivo.Antimicrob Agents Chemother. 1996 Mar;40(3):792-4. doi: 10.1128/AAC.40.3.792. Antimicrob Agents Chemother. 1996. PMID: 8851615 Free PMC article.
-
The carbocyclic analog of 2'-deoxyguanosine induces a prolonged inhibition of duck hepatitis B virus DNA synthesis in primary hepatocyte cultures and in the liver.J Virol. 1994 Feb;68(2):1059-65. doi: 10.1128/JVI.68.2.1059-1065.1994. J Virol. 1994. PMID: 8289335 Free PMC article.
-
Developments in Cell-Penetrating Peptides as Antiviral Agents and as Vehicles for Delivery of Peptide Nucleic Acid Targeting Hepadnaviral Replication Pathway.Biomolecules. 2018 Jul 16;8(3):55. doi: 10.3390/biom8030055. Biomolecules. 2018. PMID: 30013006 Free PMC article. Review.
Cited by
-
Effects of pyrimidine and purine analog combinations in the duck hepatitis B virus infection model.Antimicrob Agents Chemother. 2003 Jun;47(6):1842-52. doi: 10.1128/AAC.47.6.1842-1852.2003. Antimicrob Agents Chemother. 2003. PMID: 12760857 Free PMC article.
-
In vitro activity of 2,4-diamino-6-[2-(phosphonomethoxy)ethoxy]-pyrimidine against multidrug-resistant hepatitis B virus mutants.Antimicrob Agents Chemother. 2007 Jun;51(6):2240-3. doi: 10.1128/AAC.01440-06. Epub 2007 Mar 19. Antimicrob Agents Chemother. 2007. PMID: 17371827 Free PMC article.
-
Characterization of the antiviral effect of 2',3'-dideoxy-2', 3'-didehydro-beta-L-5-fluorocytidine in the duck hepatitis B virus infection model.Antimicrob Agents Chemother. 2000 Jan;44(1):111-22. doi: 10.1128/AAC.44.1.111-122.2000. Antimicrob Agents Chemother. 2000. PMID: 10602731 Free PMC article.
-
In vitro characterization of the anti-hepatitis B virus activity and cross-resistance profile of 2',3'-dideoxy-3'-fluoroguanosine.Antimicrob Agents Chemother. 2006 Mar;50(3):955-61. doi: 10.1128/AAC.50.3.955-961.2006. Antimicrob Agents Chemother. 2006. PMID: 16495257 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources